Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects
Year: 2019
Type: article
Study design: Clinical Trial
Source: Journal of clinical lipidology
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: evolocumab, PCSK9 inhibition, triglyceride-rich lipoproteins, type 2 diabetes, postprandial lipemia, remnant-like particles, apolipoprotein C-III, apolipoprotein B-48, VLDL triglycerides, chylomicron triglycerides, hepatic de novo lipogenesis, hepatic lipid accumulation, beta-hydroxybutyrate, statin therapy
Open Access status: green
OpenAlex ID: W2996659077
